Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.3 INR | -1.08% | +1.73% | -11.37% |
03-06 | Bodal Chemicals Limited announced that it expects to receive INR 214 million in funding | CI |
02-13 | Transcript : Bodal Chemicals Limited, Q3 2024 Earnings Call, Feb 13, 2024 |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The opinion of analysts covering the stock has improved over the past four months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company does not generate enough profits, which is an alarming weak point.
- With an expected P/E ratio at 122.1 and 19.8 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-11.37% | 111M | - | ||
+18.52% | 67.02B | A- | ||
+3.18% | 49.69B | A- | ||
+20.44% | 42.41B | B+ | ||
+23.39% | 26.65B | A- | ||
+12.41% | 19.62B | C+ | ||
+0.10% | 17.1B | B+ | ||
+4.18% | 15.64B | B+ | ||
-26.74% | 15.43B | A- | ||
-11.77% | 15.3B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- BODALCHEM Stock
- BODALCHEM Stock
- Ratings Bodal Chemicals Limited